ARMP Armata Pharmaceuticals, Inc.
ARMP Armata Pharmaceuticals, Inc.
Healthcare · Biotechnology
Market read
POC $5.04 · VWAP $6.17 · -41.0% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
ARMP Price Structure
Loading timeframes…
Reported EPS $1.20 versus analyst consensus of $-0.44 (+368.5%).
full note →Against street estimates
How ARMP's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about ARMP from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled today · Oct 23
- Armata Pharmaceuticals, Inc. (ARMP) Latest Stock News & Headlines - Yahoo Finance
- ARMP News Today | Why did Armata Pharmaceuticals stock drop today? $ARMP
- Armata Pharmaceuticals Announces Financial Results For The Second Quarter 2026 And Provides A Corporate Update 302847580
- Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update - May 13, 2026
- Armata Pharmaceuticals (ARMP) Investor Relations, Earnings Summary & Outlook
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
ARMP research tape
11 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.